Paper36915713
Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways.
Zhang F and 12 others. Regen Biomater, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways. Papers, record 36915713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36915713
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 39569075 | Correction to: Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways. | https://conductscience.org/library/papers/39569075 |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27899961 | The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27899961 | PubMed |
| 2 | 23201163 | Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. | Cancer Cell | 2012 | https://conductscience.org/library/papers/23201163 | PubMed |
| 3 | 28070573 | Nanoparticle delivery of Wnt-1 siRNA enhances photodynamic therapy by inhibiting epithelial-mesenchymal transition for oral cancer. | Biomater Sci | 2017 | https://conductscience.org/library/papers/28070573 | PubMed |
| 4 | 30844107 | Hypoxia/pseudohypoxia-mediated activation of hypoxia-inducible factor-1α in cancer. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30844107 | PubMed |
| 5 | 28752598 | Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications. | Adv Healthc Mater | 2017 | https://conductscience.org/library/papers/28752598 | PubMed |
| 6 | 32296047 | Molecular principles of metastasis: a hallmark of cancer revisited. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32296047 | PubMed |
| 7 | 21741598 | A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. | Cancer Cell | 2011 | https://conductscience.org/library/papers/21741598 | PubMed |
| 8 | 30451972 | Wnt-β-catenin signalling in liver development, health and disease. | Nat Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/30451972 | PubMed |
| 9 | 34952829 | Epigenetic basis and targeting of cancer metastasis. | Trends Cancer | 2022 | https://conductscience.org/library/papers/34952829 | PubMed |
| 10 | 23390366 | All-trans retinoic acid-incorporated nanoparticles of deoxycholic acid-conjugated dextran for treatment of CT26 colorectal carcinoma cells. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/23390366 | PubMed |
| 11 | 32334405 | Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. | Transl Oncol | 2020 | https://conductscience.org/library/papers/32334405 | PubMed |
| 12 | 34197896 | Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs). | Adv Drug Deliv Rev | 2021 | https://conductscience.org/library/papers/34197896 | PubMed |
| 13 | 28741564 | Surviving at a Distance: Organ-Specific Metastasis. | Trends Cancer | 2015 | https://conductscience.org/library/papers/28741564 | PubMed |
| 14 | 30975895 | Context-dependent EMT programs in cancer metastasis. | J Exp Med | 2019 | https://conductscience.org/library/papers/30975895 | PubMed |
| 15 | 35332121 | Notch signaling pathway: architecture, disease, and therapeutics. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35332121 | PubMed |
| 16 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 17 | 29035746 | The exploration of endocytic mechanisms of PLA-PEG nanoparticles prepared by coaxialtri-capillary electrospray-template removal method. | Colloids Surf B Biointerfaces | 2018 | https://conductscience.org/library/papers/29035746 | PubMed |
| 18 | 29665439 | Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer. | Nanomedicine | 2018 | https://conductscience.org/library/papers/29665439 | PubMed |
| 19 | 30594349 | EMT Transition States during Tumor Progression and Metastasis. | Trends Cell Biol | 2019 | https://conductscience.org/library/papers/30594349 | PubMed |
| 20 | 24816129 | A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer. | Eur J Pharm Biopharm | 2014 | https://conductscience.org/library/papers/24816129 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42823964 | A biomaterials roadmap from retinoic acid biology to kidney regenerative therapy. | iScience | 2026 | https://conductscience.org/library/papers/42823964 | PubMed |
| 41437379 | Dual-site spatiotemporal and simultaneous inhibition on PIN1 via arsenic-retinoic albumin nanoparticles enables synergistic oncotherapy. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41437379 | PubMed |
| 40385538 | Temperature-sensitive sodium beta-glycerophosphate/chitosan hydrogel loaded with all-trans retinoic acid regulates Pin1 to inhibit the formation of spinal cord injury-induced rat glial scar. | Bioeng Transl Med | 2025 | https://conductscience.org/library/papers/40385538 | PubMed |
| 39886975 | Pin1 as a central node in oncogenic signaling: Mechanistic insights and clinical prospects (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/39886975 | PubMed |
| 39199746 | Supercritical Fluids: An Innovative Strategy for Drug Development. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/39199746 | PubMed |
| 38476678 | Cancer cell response to extrinsic and intrinsic mechanical cue: opportunities for tumor apoptosis strategies. | Regen Biomater | 2024 | https://conductscience.org/library/papers/38476678 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36915713
GET https://conductscience.org/api/papers/v1/36915713/references?page=2